Cite

HARVARD Citation

    Hexner, E. et al. (n.d.). Phase I dose escalation study of lestaurtinib in patients with myelofibrosis. Leukemia & lymphoma. 56 (9), pp. 2543-2551. [Online]. 
  
Back to record